Has Rana Afifi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,783 in general payments to Rana Afifi, MD across 164 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rana Afifi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rana Afifi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rana Afifi, MD

Vascular Surgery · Houston, TXNPI 1013340132

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $26,538 of the $40,783 with a category attached, or 65.1%. Medtronic accounts for 87.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $14,097 and has fallen 78.3% since, to $3,054 in 2025.

$40,783in general payments, 2019–2025

Across 164 payments — averaging $248.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$36K
W. L. Gore & Associates, Inc.$2K
Penumbra, Inc.$753
Cook Medical LLC$748
Bard Peripheral Vascular, Inc.$422
Shockwave Medical, Inc$399
plus $1K from 10 others

$33,714in research payments, 2019–2025

Across 10 payments — averaging $3371.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$28K
W. L. Gore & Associates, Inc.$6K

What the payments were for

Consulting fees$1,4634%
Speaking & faculty fees$26,53865%
Travel & lodging$3,3638%
Food & beverage$9,38123%
Education$380%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	88	$35,507
W. L. Gore & Associates, Inc.	28	$1,838
Penumbra, Inc.	6	$753
Cook Medical LLC	8	$748
Bard Peripheral Vascular, Inc.	12	$422
Shockwave Medical, Inc	2	$399
Silk Road Medical, Inc.	3	$345
Bolton Medical Inc	3	$263
Inari Medical, Inc.	2	$172
Atricure, Inc.	1	$97
Boston Scientific	3	$79
Lemaitre Vascular, Inc.	3	$58
Angiodynamics, Inc.	1	$37
Wound Management Technologies, Inc	2	$33
Cardiovascular Systems Inc.	1	$18
Baxter Healthcare	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,783 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.

See all vascular surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$39,588

Medicare patients

Services billed

164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	11	$108

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Houston

Alan LumsdenHouston$742K
Gustavo OderichHouston$319K
Jean BismuthHouston$243K
Ali AzizzadehHouston$181K
Steven MaximusHouston$140K
Samuel LeonardHouston$96K
Charudatta BavareHouston$72K
Philip AuyangHouston$43K
Jayer ChungHouston$42K
Linda leHouston$40K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →